Well Done LLC’s iShares Biotechnology ETF IBB Stock Holding History

Well Done LLC’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-5,481	Closed	-$749K	–	141
2020 Q2	$749K	Buy	+5,481	New	+$699K	0.21%	69
2018 Q2	–	Sell	-546	Closed	-$58K	–	302
2018 Q1	$58K	Buy	+546	New	+$60.5K	0.02%	217
2016 Q4	–	Sell	-5,790	Closed	-$2.16K	–	96
2016 Q3	$2.16K	Hold	5,790	–	–	0.78%	26
2016 Q2	$497K	Hold	5,790	–	–	0.18%	51
2016 Q1	$503K	Buy	5,790 +3,177	+122%	+$284K	0.18%	48
2015 Q4	$295K	Buy	+2,613	New	+$284K	0.1%	65

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Well Done LLC's IBB Position: Q3 2020 in Review

Well Done LLC sold out of iShares Biotechnology ETF (IBB) in Q3 2020, closing a stake of 5,481 shares — an estimated $749K sold.

Well Done LLC first reported a position in IBB in Q4 2015 and held it in 6 quarters. The position peaked at $749K in Q2 2020. 784 funds tracked by Wall St. Rank hold IBB as of Q3 2020.

Well Done LLC reported no remaining iShares Biotechnology ETF position as of Q3 2020 after selling out during the quarter.
Well Done LLC sold 5,481 iShares Biotechnology ETF shares in Q3 2020, an estimated $749K.
Well Done LLC first reported a position in iShares Biotechnology ETF in Q4 2015 and held it in 6 quarters.
Well Done LLC's iShares Biotechnology ETF position peaked at $749K in Q2 2020.
784 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2020.

Based on Well Done LLC's 13F filing for Q3 2020, filed 19 Oct 2020.